Valvular & structural heart disease

Mitral Valve Repair for Degenerative Mitral Regurgitation (MR) With Moderate or Less Tricuspid Regurgitation: 2-Year Outcomes From a Multicenter Echocardiographic Core Laboratory-Adjudicated Cohort

J Am Coll CardiolPublished Post hoc analysis of a randomised trial

Authors' conclusion

In this international trial with echocardiographic core laboratory adjudication, the rate of survival free from MV reoperation or any episode of severe MR during 2 years was 92% in patients with DMR and concomitant TV disease.

Study context

Population
Patients undergoing mitral valve (MV) repair for degenerative MR with concomitant tricuspid valve (TV) disease (moderate or less tricuspid regurgitation), 2016–2018eligible of 401 randomised
Participants
314 patients
Primary endpoint
Treatment failure: all-cause mortality, recurrent severe MR or MV reoperation
Follow-up
2 years
Methodological details39 sites, echocardiographic core laboratory adjudication
  • 39 sites
  • Echocardiographic core laboratory adjudication

Primary result

As reported in the abstract

Death, MV reoperation or severe MR

Incidence of death, MV reoperation or severe MR

8.0%

25 of 313

Further findings

OutcomeOR (95% CI)P value
Treatment failure by leaflet pathology (anterior or bileaflet vs posterior) · 2 years2.48 (1.09–5.68)P = 0.03

MR at discharge

Moderate MR
1.0% (3 of 307)
Severe MR
0.7% (2 of 307)

All-cause mortality · 30 days

30-day all-cause mortality
1.0%

Death and MV reoperation · 2 years

Died
3.5% (11 of 314)
MV reoperation
2.2% (7 of 314)

Echocardiographic findings in survivors free of MV reoperation · 2 years

Moderate MR
9.2% (27 of 295)
Severe MR
1.4% (4 of 295)
Mean MV gradient >5 mm Hg
2.5% (7 of 275)

Original publication

Mitral Valve Repair for Degenerative MR With Moderate or Less Tricuspid Regurgitation: 2-Year Outcomes From a Multicenter Echocardiographic Core Laboratory-Adjudicated Cohort. J Am Coll Cardiol. Published 18 February 2026. doi:10.1016/j.jacc.2025.12.065

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.